Results 31 to 40 of about 1,582,509 (353)

Global economic burden per episode for multiple diseases caused by group A Streptococcus

npj Vaccines, 2023
Considering the lack of existing evidence on economic burden for diseases caused by group A Streptococcus, we estimated the economic burden per episode for selected diseases.
Jung-Seok Lee, Sol Kim, Jean-Louis Excler, Jerome H. Kim, Vittal Mogasale   +4 more
doaj   +1 more source

Effect of maternal separation and transportation stress on the bovine upper respiratory tract microbiome and the immune response to resident opportunistic pathogens

Animal Microbiome, 2021
Background The bovine upper respiratory tract (URT) microbiome includes opportunistic pathogens that cause respiratory disease and stress associated with maternal separation and transportation contributes to the severity of this respiratory disease ...
Nilusha Malmuthuge, Angela Howell, Natasa Arsic, Tracy Prysliak, Jose Perez-Casal, Philip Griebel   +5 more
doaj   +1 more source

Vaccine hesitancy: the next challenge in the fight against COVID-19

European Journal of Epidemiology, 2020
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy.
A. Dror, N. Eisenbach, S. Taiber, N. Morozov, Matti Mizrachi, Asaf Zigron, S. Srouji, E. Sela   +7 more
semanticscholar   +1 more source

Vaccine adjuvants: mechanisms and platforms

Signal Transduction and Targeted Therapy, 2023
Adjuvants are indispensable components of vaccines. Despite being widely used in vaccines, their action mechanisms are not yet clear. With a greater understanding of the mechanisms by which the innate immune response controls the antigen-specific ...
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu, Xiaohe Tian   +6 more
semanticscholar   +1 more source

Vaccines, Vaccination, and Vaccinology [PDF]

The Journal of Infectious Diseases, 2003
Although the demonstration in 1796 by Edward Jenner that vaccinia virus could protect against smallpox was epochal, he was following the path opened by the ancients who had used the smallpox virus itself in the practice of variolation. The work of Louis Pasteur on chicken cholera opened the way to vaccine development in the laboratory.
openaire   +2 more sources

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence [PDF]

, 2012
Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals ...
Assir N, Lang, Pierre-Olivier, Govind, Sheila, Aspinall R, Mendes A, Mendes, Aline, Socquet, Jennifer, Govind S, Socquet J, Assir, Noémie, Lang PO, Aspinall, Richard   +11 more
core   +1 more source

ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine efficacy against the B.1.351 variant

New England Journal of Medicine, 2021
Background Assessing safety and efficacy of Covid-19 vaccines in different populations is essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern including the B.1.351 (501Y.V2) variant first identified in South Africa.
S. Madhi, V. Baillie, C. Cutland, M. Voysey, A. Koen, L. Fairlie, S. Padayachee, K. Dheda, S. Barnabas, Q. Bhorat, Carmen Briner, G. Kwatra, Khatija Ahmed, P. Aley, Sutika Bhikha, J. Bhiman, A. Bhorat, Jeanine du Plessis, A. Esmail, Marisa M. Groenewald, E. Horne, Shi-Hsia Hwa, A. Jose, T. Lambe, M. Laubscher, M. Malahleha, Masebole Masenya, M. Masilela, Shakeel Mckenzie, Kgaogelo Molapo, A. Moultrie, S. Oelofse, Faeezah Patel, S. Pillay, S. Rhead, H. Rodel, Lindie Rossouw, Carol Taoushanis, H. Tegally, Asha Thombrayil, Samuel van Eck, C. K. Wibmer, N. Durham, E. J. Kelly, T. Villafana, Sarah C. Gilbert, A. Pollard, T. de Oliveira, P. Moore, A. Sigal, A. Izu   +50 more
semanticscholar   +1 more source

Vaccine and Vaccination: On Field Research

Vaccines, 2022
Historically, vaccinations have enabled the eradication, elimination, and control of many debilitating diseases [...]
Francesca Gallè, Christian Napoli
openaire   +3 more sources

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

, 2020
Tuberculosis still claims more lives than any other pathogen, and a vaccine better than BCG is urgently needed. One of the challenges for novel TB vaccines is to protect against all Mycobacterium tuberculosis lineages, including the most virulent ones ...
권기웅, 신성재
core   +1 more source

SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness

Nature, 2020
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
Kizzmekia S. Corbett, D. Edwards, S. Leist, Olubukola M. Abiona, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie, S. Himansu, A. Schäfer, Cynthia Ziwawo, Anthony T. DiPiazza, Kenneth H. Dinnon, Sayda M. Elbashir, C. Shaw, Angela Woods, Ethan J. Fritch, David R. Martinez, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Geoffrey B. Hutchinson, Kai Wu, C. Henry, Kapil Bahl, Dario Garcia-Dominguez, Ling-Zhi Ma, Isabella Renzi, W. Kong, S. Schmidt, Lingshu Wang, Yi Zhang, Emily Phung, Lauren A. Chang, Rebecca J. Loomis, N. Altaras, Elisabeth Narayanan, Mihir Metkar, Vladimir Presnyak, Cuiping Liu, M. Louder, Wei Shi, K. Leung, E. Yang, A. West, K. Gully, Laura J. Stevens, Nianshuang Wang, D. Wrapp, N. Doria-Rose, Guillaume B. E. Stewart-Jones, Hamilton Bennett, Gabriela Alvarado, M. Nason, T. Ruckwardt, J. McLellan, M. Denison, J. Chappell, Ian N. Moore, Kaitlyn M. Morabito, J. Mascola, R. Baric, A. Carfi, B. Graham   +61 more
semanticscholar   +1 more source